pemigatinib
incyte,specialised therapeutics
research on fgfr2 fusion in #cholangiocarcinoma is an incredible experience. doing research with doi: 10.1002/hep.31799 discuss data with #orestesegatto being part of fight-202 &gt; getting approval by ema/ fda 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine